In my opinion this is a go big or go home shot. one last effort for critical to make it to an EUA. If it falls short, focus on LH and remove ourselves from playing with critical. Last Winter in a CC, NP mentioned that one of the execs big payoff bonuses was an EUA. It was either last November or December when shareholders questioned why the CFO had sold off a lot of shares. So the only application we have for an EUA in the near future is Covid Critical.. Looking forward to more of a focus on Cancer, HIV and autoimmune diseases which will be the core of this business going forward....